Biomerica (BMRA) Share-based Compensation Growth (3y) (2014 - 2026)
Biomerica (BMRA) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.36% |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 | -46.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -46.74% |
| Nov 30, 2025 | -39.05% |
| Aug 31, 2025 | -24.09% |
| May 31, 2025 | -28.91% |
| Feb 28, 2025 | -34.60% |
| Nov 30, 2024 | 85.64% |
| Aug 31, 2024 | -37.78% |
| May 31, 2024 | -15.01% |
| Feb 29, 2024 | -13.33% |
| Nov 30, 2023 | -37.36% |
| Aug 31, 2023 | 254.75% |
| May 31, 2023 | -19.70% |
| Feb 28, 2023 | 34.47% |
| Nov 30, 2022 | 121.84% |
| Aug 31, 2022 | 273.17% |
| May 31, 2022 | 299.64% |
| Feb 28, 2022 | 33.29% |
| Nov 30, 2021 | 185.42% |
| Aug 31, 2021 | 240.67% |
| May 31, 2021 | 253.13% |